Seiji Okada

12.1k citations
367 papers · 8.9k indexed · h-index 46
Topics
Immune Cell Function and Interaction (56 papers)Lymphoma Diagnosis and Treatment (38 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers)

In The Last Decade

Seiji Okada

354 papers receiving 8.7k citations

Peers

Seiji Okada
Comparison fields: 5 of 142
  • Molecular Biology 3.5k
  • Immunology 3.0k
  • Oncology 2.0k
  • Pathology and Forensic Medicine 1.0k
  • Surgery 889
Replace Florence M. Hofman with:
Florence M. Hofman United States
Koichi Nakajima Japan
Kiyoshi Yasukawa Japan
Joachim W. Ellwart Germany
Armand Bensussan France
Ivan D. Horak United States
Tomohiko Tamura Japan
Lin‐Feng Chen United States
Peter J. Nelson Germany
Philippe Bouillet Australia
Seiji Okada relative to Florence M. Hofman United States Florence M. Hofman's profile →
Citations per field
00.5×
Florence M. Hofman · 1×
Citations per year

Countries citing papers authored by Seiji Okada

Since Specialization
Citations

This map shows the geographic impact of Seiji Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Okada more than expected).

Fields of papers citing papers by Seiji Okada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Okada. The network helps show where Seiji Okada may publish in the future.

Co-authorship network of co-authors of Seiji Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Seiji Okada. A scholar is included among the top collaborators of Seiji Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seiji Okada. Seiji Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 3
5 2
6 0
7 1
8 4
9 2
10 6
11 4
12 9
13 14
14 12
15 5
16 22
17 6
18 30
19 76
20 37

About Seiji Okada

Seiji Okada is a scholar working on Virology, Immunology and Oncology, having authored 367 papers that have together received 8.9k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (56 papers), Lymphoma Diagnosis and Treatment (38 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (2.0k citations) and Virology (348 citations). Seiji Okada has collaborated with scholars based in Japan, Thailand and United States. Frequent co-authors include Ryusho Kariya, Toshio Suda, Takeshi Tokuhisa, Masahiko Hatano, Kulthida Vaeteewoottacharn, Hiromitsu Nakauchi, Kikuko Nagayoshi, Shinya Suzu, Yoshimasa Mıura and Sopit Wongkham. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026